74 results on '"S. Feliciano"'
Search Results
2. Photobiomodulation therapy's effects on cardiac fibrosis activation after experimental myocardial infarction
- Author
-
Regiane dos S. Feliciano, Martha T. Manchini, Allan L. B. Atum, Gabriel Almeida da Silva, Ednei L. Antônio, Andrey J. Serra, Paulo J. F. Tucci, Ramon Andrade de Mello, Maria C. Chavantes, Ovidiu C. Baltatu, and José A. Silva Júnior
- Subjects
MicroRNAs ,Myocardial Infarction ,Animals ,Surgery ,Dermatology ,RNA, Messenger ,Low-Level Light Therapy ,Fibrosis ,Rats - Abstract
Ischemic heart disease is the leading cause of death worldwide, and interventions to reduce myocardial infarction (MI) complications are widely researched. Photobiomodulation therapy (PBMT) has altered multiple biological processes in tissues and organs, including the heart.This study aimed to assess the temporal effects of PBMT on cardiac fibrosis activation after MI in rats. In this proof-of-concept study, we monitored the change in expression patterns over time of genes and microRNAs (miRNAs) involved in the formation of cardiac fibrosis post-MI submitted to PBMT.Experimental MI was induced, and PBMT was applied shortly after coronary artery ligation (laser light of wavelength 660 nm, 15 mW of power, energy density 22.5 J/cmPBMT, when applied after ischemia, reversed the changes in mRNA expression of myocardial extracellular matrix genes induced by MI. Surprisingly, PBMT modified cardiac miRNAs expression related to fibrosis replacement in the myocardium. Expression correlations between myocardial mRNAs were assessed. The correlation coefficient between miRNAs and target mRNAs was also determined. A positive correlation was detected among miR-21 and transforming growth factor beta-1 mRNA. The miR-29a expression negatively correlated to Col1a1, Col3a1, and MMP-2 mRNA expressions. In addition, we observed that miR-133 and Col1a1 mRNA were negatively correlated.The results suggest that PBMT, through the modulation of gene transcription and miRNA expressions, can interfere in cardiac fibrosis activation after MI, mainly reversing the signaling pathway of profibrotic genes.
- Published
- 2022
3. iso-Kaurenoic acid from Wedelia paludosa D.C.
- Author
-
Ronan Batista, Pablo A. García, María Ángeles Castro, José M. Miguel Del Corral, Arturo S. Feliciano, and Alaíde B. de Oliveira
- Subjects
Asteraceae ,ácido iso-caurenóico ,sílica gel impregnada com nitrato de prata ,Wedelia paludosa D.C ,iso-kaurenoic acid ,silica gel impregnated with silver nitrate ,Science - Abstract
A recent reinvestigation of aerial parts of Wedelia paludosa D.C. is described and reports, for the first time, the isolation of iso-kaurenoic acid from this species.Uma recente reinvestigação das partes aéreas de Wedelia paludosa D.C. é descrita e relata, pela primeira vez, o isolamento do ácido iso-caurenóico desta espécie.
- Published
- 2010
- Full Text
- View/download PDF
4. The gray zone of myocardial fibrosis is a better predictor of ventricular arrhythmias than total myocardial fibrosis in patients with previous myocardial infarction
- Author
-
M Mendes, P Lopes, Francisco Bello Morgado, Pedro J. Freitas, Bruno M.L. Rocha, Pedro Adragão, Diogo Cavaco, Carla Saraiva, G Cunha, D. Chotalal, J A Sousa, Pedro Carmo, S Feliciano, A Ferreira, and João Abecasis
- Subjects
medicine.medical_specialty ,business.industry ,Internal medicine ,medicine ,Cardiology ,Myocardial fibrosis ,In patient ,cardiovascular diseases ,Myocardial infarction ,Cardiology and Cardiovascular Medicine ,medicine.disease ,business - Abstract
Background Current sudden cardiac death (SCD) risk stratification relies heavily on the assessment of left ventricular ejection fraction (LVEF), but markers that could refine risk assessment are needed. Total fibrosis mass (TFM) and “gray zone” of myocardial fibrosis (GZF) on late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) have been proposed as potential arrhythmogenic substrates. The aim of our study was to determine whether TFM and GZF can predict the occurrence of ventricular arrhythmias in patients with previous myocardial infarction. Methods We performed a single centre retrospective study enrolling all consecutive patients with previous myocardial infarction undergoing LGE-CMR before implantable cardioverter-defibrillator (ICD) implantation for primary or secondary prevention. TFM and GZF were defined as myocardial tissue with signal-intensities >6 SD and 2–6 SD above the mean of reference myocardium, respectively. The primary endpoint was a composite of sudden arrhythmic death, appropriate ICD shock, ventricular fibrillation (VF), or sustained ventricular tachycardia (VT) as detected by the device. Results A total of 55 patients (mean age 62±12 years, 87% male, mean LVEF 30% ± 8%) were included. During a mean follow-up period of 34±15 months, 10 patients reached the primary endpoint (8 appropriate ICD shock, 2 sustained VT or VF). Patients who attained the primary endpoint had similar TFM (28.6g ± 14.5 vs. 23.1g ± 14.5; P=0.283) but larger GZF (25.3g ± 11.0 vs 15.6g ± 7.3; P=0.001). After adjustment for LVEF, GZF remained independently associated with the composite arrhythmic endpoint (adjusted hazard ratio [aHR]: 1.10; 95% CI: 1.03–1.17; P=0.005), whereas TFM did not (aHR: 1.02; 95% CI: 0.98–1.06; P=0.394). Decision tree analysis identified 16.4g of GZF as the best cut-off to predict life-threatening arrhythmic events. The primary endpoint occurred in 9 out of the 22 patients (41%) with GZF >16.4g, but in only 1 of the 33 patients (3%) with GZF ≤16.4g – Figure. Conclusions The extent of GZF seems to be a better predictor of ventricular arrhythmias than TFM. This LGE-CMR parameter may be useful to identify a subgroup of patients with previous myocardial infarction at an increased risk of life-threatening arrhythmic events. Funding Acknowledgement Type of funding sources: None.
- Published
- 2021
- Full Text
- View/download PDF
5. Idiopathic HFrEF. Is there room left for defibrillators?
- Author
-
Francisco Bello Morgado, F Mendes, I Santos, J Carmo, F Gama, S Feliciano, Daniel Matos, Anaí Durazzo, Pedro Carmo, F Costa, Pedro Adragão, Marina Santos Carvalho, Diogo Cavaco, and G Rodrigues
- Subjects
Coronary angiography ,medicine.medical_specialty ,Ejection fraction ,business.industry ,medicine.medical_treatment ,Cardiac resynchronization therapy ,medicine.disease ,Sudden cardiac death ,Implantable defibrillators ,New York Heart Association Classification ,Sustained ventricular tachycardia ,Internal medicine ,Heart failure ,medicine ,Cardiology ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background and aim Prophylactic implantation of an implantable cardioverter-defibrillator (ICD) is class 1 recommendation for heart failure (HF) patients with reduced ejection fraction (HFrEF) even though its proven advantage is weaker among nonischemic aetiology. In fact, in an era where both optimal medical therapy (OMT) and cardiac resynchronization therapy (CRT) significantly reduce sudden cardiac death (SCD), it is questionable whether ICD still have additional value. The aim of this study was to assess the current benefit of ICDs in preventing sudden cardiac death through resuscitated cardiac arrest (RCA), appropriate therapy for sustained ventricular tachycardia (VT) or fibrillation (VF) in a contemporary population of idiopathic HFrEF patients. Methods Single-centre retrospective study of consecutive symptomatic (NYHA class II to IV) idiopathic HFrEF patients with an ICD (either alone or in association with CRT), and remote monitoring with the corresponding software (MerlinTM, LatitudeTM, CarelinkTM, MicroPortTM or BiotronikTM) to assure appropriate event supervising. Idiopathic aetiology was assumed after excluding other probable causes. Coronary angiogram was required to exclude ischemic aetiology. Only those with prophylactic ICD implantation were included. RCA was defined as collapse with clinical signs of cardiac arrest and VF or VT appropriately terminated by ICD. In order to be sustained, VT episode had to have last at least 30 seconds. Results From 781 remote monitoring controlled patients, a total of 187 consecutive symptomatic idiopathic HFrEF patients with an ICD (125 men, mean age 64±18 years) were enrolled. Patients were on optimal medical therapy (ACEi/ARB: n=168, 90%; BB: n=154, 82%; mineralocorticoid antagonists: n=91, 49%; CRT: n=130, 70%; see Table). After a median follow-up of 99 months (IQR 62.2), RCA occurred in 10.7% (n=20) and 36.9% (n=69) had appropriately terminated VT. Both left ventricular ejection fraction (LVEF) improvement and CRT implantation did not independently reduce the incidence of RCA and VT requiring ICD therapy (OR, 1.02; 95% CI, 0.99–1.05; P=0.146 and OR, 0.85; 95% CI, 0.34–2.13; P=0.728; respectively). All cause mortality was 20 (10.7%). Inappropriate therapy was given as shocks to 41 patients (21.9%) and as antitachycardia pacing (ATP) to 30 (16%), opposing with appropriately given therapy to 43 (23%) and 63 (33.7%) patients, respectively (see Figure), contributing to a net clinical benefit (NCB) of 18.8%, favouring ICD implantation. Conclusion In this contemporaneous real-world population of symptomatic idiopathic HFrEF patients, episodes of impending cardiac death were frequent. Prophylactic ICD implantation seems to have added further benefit reducing SCD on top of optimal medical therapy, LVEF improvement and coexisting CRT. Funding Acknowledgement Type of funding source: None
- Published
- 2020
- Full Text
- View/download PDF
6. Healthy cartilage tissues exhibit superior properties as compared to the diseased ones from inflamed traumatic joints
- Author
-
Ivan Martin, Francine Wolf, L. Iselin, Markus P. Arnold, Lina Acevedo, S. Feliciano, Karoliina Pelttari, G. Salzman, Andrea Barbero, M.H. Berkelaar, G. Pangenstert, and Nicole Vogel
- Subjects
Pathology ,medicine.medical_specialty ,Rheumatology ,business.industry ,Biomedical Engineering ,Medicine ,Orthopedics and Sports Medicine ,business ,Cartilage tissues - Published
- 2020
- Full Text
- View/download PDF
7. 207.2: Immunomodulatory effect of thalidomide in the kidney of donor brain death experimental model
- Author
-
Paulo Mp Fernandes, Regiane S Feliciano, Rafael Pepineli, Humberto Dellê, Liliane Moreira Ruiz, Alexandre C Sanatana, Luis M Neri, Amanda S Schust, Natalia Aparecida Nepomuceno, Eberval Gadelha Figueiredo, Filipe M. O. Silva, and Ana Cg Sala
- Subjects
Thalidomide ,Transplantation ,Kidney ,medicine.anatomical_structure ,Experimental model ,business.industry ,medicine ,Pharmacology ,business ,medicine.drug - Published
- 2019
- Full Text
- View/download PDF
8. Comparison of exact matching and calibration curve quantification methods for glucose in human serum GC-IDMS analysis and their application for the development of certified reference materials
- Author
-
Márcia N. S. de la Cruz, Rodrigo F. M. Freitas, Ana Carolina S. Feliciano, Juliana Barrabin, Bruno C. Garrido, Wagner Wollinger, and Gabriella A. Machado
- Subjects
Analyte ,Accuracy and precision ,Quantification methods ,Calibration curve ,General Chemical Engineering ,Exact matching ,General Chemistry ,Standard deviation ,Certified reference materials ,Statistics ,Measurement uncertainty ,Safety, Risk, Reliability and Quality ,Instrumentation ,Algorithm - Abstract
The establishment of a precise and accurate method for the determination of the analyte is the first step in the development of certified reference materials (CRMs), which play a key role in metrological traceability. To assist the production of a glucose CRM in human serum for clinical chemistry routine tests, we developed a gas chromatography-isotope dilution mass spectrometry method using trimethylsilylation and performed two calibration techniques: exact matching approach and calibration curve. Performance of the method and calibration techniques were evaluated for their suitability for the characterization of a CRM candidate carrying out studies to assign the property value and to assure homogeneity as well as short- and long-term stability. Both calibration approaches were equivalent in terms of accuracy and precision and presented bias lower than 1.0 % with relative standard deviations lower than 3.0 %. Relative measurement uncertainties obtained with the exact matching approach calibration method were between 1.0 % and 2.5 % and were lower than the ones obtained with calibration curve method. This finding justifies the use of the time-consuming exact matching method for the assignment of the property value, while the calibration curve procedure suits the other certification studies.
- Published
- 2015
- Full Text
- View/download PDF
9. Performance of nasal chondrocytes in an osteoarthritic environment
- Author
-
Karoliina Pelttari, Gina Lisignoli, Martin Haug, S. Feliciano, Andrea Barbero, Jeroen Geurts, Ivan Martin, Paola Occhetta, L. Acevedo, and C. Manferdini
- Subjects
Rheumatology ,business.industry ,Biomedical Engineering ,Medicine ,Orthopedics and Sports Medicine ,business - Published
- 2018
- Full Text
- View/download PDF
10. Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis
- Author
-
V R, Bollela, E I, Namburete, C S, Feliciano, D, Macheque, L H, Harrison, and J A, Caminero
- Subjects
Patient Selection ,Clinical Decision-Making ,DNA Mutational Analysis ,Antitubercular Agents ,Microbial Sensitivity Tests ,Mycobacterium tuberculosis ,Catalase ,Article ,Bacterial Proteins ,Predictive Value of Tests ,Drug Resistance, Multiple, Bacterial ,Mutation ,Tuberculosis, Multidrug-Resistant ,Isoniazid ,Humans ,Ethionamide ,Oxidoreductases ,Brazil ,Mozambique - Abstract
Depending on the presence of mutations that determine isoniazid (INH) susceptibility (katG and inhA), Mycobacterium tuberculosis may be susceptible to high doses of INH or ethionamide (ETH).To describe the INH resistance profile and association of katG mutation with previous INH treatment and level of drug resistance based on rapid molecular drug susceptibility testing (DST) in southern Brazil and central Mozambique.Descriptive study of 311 isolates from Ribeirão Preto, São Paulo, Brazil (2011-2014) and 155 isolates from Beira, Mozambique (2014-2015). Drug resistance patterns and specific gene mutations were determined using GenoType(®) MTBDRplus.katG gene mutations were detected in 12/22 (54.5%) Brazilian and 32/38 (84.2%) Mozambican isolates. inhA mutations were observed in 9/22 (40.9%) isolates in Brazil and in 4/38 (10.5%) in Mozambique. Both katG and inhA mutations were detected in respectively 1/22 (5%) and 2/38 (5.2%). The difference in the frequency of katG mutations in Brazil and Mozambique was statistically significant (P = 0.04). katG mutations were present in 68.8% (33/48) of patients previously treated with INH and 31.2% (15/48) of patients without previous INH. This difference was not statistically significant (P = 0.223).INH mutations varied geographically; molecular DST can be used to guide and accelerate decision making in the use of ETH or high doses of INH.
- Published
- 2016
11. Constitutive expression of E2F-1 leads to p21-dependent cell cycle arrest in S phase of the cell cycle
- Author
-
Senthil K. Radhakrishnan, Eugene S. Kandel, Angela L. Tyner, Claudine S. Feliciano, Andrea Haegebarth, Feridoon Najmabadi, and Andrei L. Gartel
- Subjects
Cyclin-Dependent Kinase Inhibitor p21 ,Cancer Research ,Cell cycle checkpoint ,Recombinant Fusion Proteins ,Cell Cycle Proteins ,Biology ,S Phase ,Mice ,Cyclins ,Genetics ,Animals ,Humans ,E2F ,Molecular Biology ,Transcription factor ,S phase ,Cell growth ,Cell cycle ,CDKN1A Gene ,E2F Transcription Factors ,Cell biology ,DNA-Binding Proteins ,Receptors, Estrogen ,NIH 3T3 Cells ,Cell Division ,E2F1 Transcription Factor ,Transcription Factors - Abstract
p21 is a potent inhibitor of cyclin-dependent kinases capable of arresting cell cycle progression. p21 is primarily regulated at the transcriptional level by several transcription factors, including p53. Previously, we reported that certain members of the E2F family of transcription factors may activate p21 transcription via a p53-independent mechanism. To further elucidate the consequences of E2F-1-regulated induction of p21, we developed cell lines with a tamoxifen-dependent form of E2F-1. We confirmed direct interaction of E2F-1 with the proximal region of the p21 promoter. Interestingly, elevated E2F-1 activity was sufficient to arrest a substantial subset of cells in S phase and this effect was correlated to and dependent on the induction of p21 protein. Since E2F proteins control genes required for cell cycle progression and are activated by various oncogenic events, we believe that the p21-dependent arrest described in this report represents an additional mechanism that guards against unrestricted cell proliferation.
- Published
- 2004
- Full Text
- View/download PDF
12. A New Method for Determining the Status of p53 in Tumor Cell Lines of Different Origin
- Author
-
Claudine S. Feliciano, Angela L. Tyner, and Andrei L. Gartel
- Subjects
Transcriptional Activation ,Cancer Research ,Cell cycle checkpoint ,Transcription, Genetic ,Tumor suppressor gene ,DNA damage ,Breast Neoplasms ,Biology ,Transactivation ,Retrovirus ,Tumor Cells, Cultured ,medicine ,Humans ,General Medicine ,Genes, p53 ,beta-Galactosidase ,medicine.disease ,biology.organism_classification ,Retroviridae ,Oncology ,Apoptosis ,Colonic Neoplasms ,Cancer research ,Adenocarcinoma ,Biological Assay ,Tumor Suppressor Protein p53 ,CDK inhibitor - Abstract
The tumor suppressor p53 is the most frequently mutated gene in human tumors. In response to DNA damage, aberrant growth signals, or chemotherapeutic drugs, p53 is stabilized and induces apoptosis and/or cell cycle arrest. While the mechanisms of p53-dependent apoptosis are not well understood, p53-dependent cycle arrest is primary mediated by the CDK inhibitor p21. p53 is a transcriptional activator and it is not surprising that a majority of p53 mutations occur in the core DNA binding domain and affect DNA binding and transactivation of p53 targets in tumors. We used the capability of p53 to activate transcription for developing a new assay that permits rapid determination of the status of p53 in cancer cell lines of different origin. Our strategy involved using a retrovirus containing a p53-regulated lacZ reporter gene that was introduced into colon and breast tumor cell lines to determine p53 status. Simple staining for beta-galactosidase allowed us to confirm that the colon cancer cell lines LIM1215 and HCT116, as well as the breast cancer cell line MCF7. have wild-type p53, and the colon cancer cell line Caco-2 as well as breast cancer cell lines MDA-MB-435 and MDA-MB-231 have mutant p53. This method may be applied to novel cell lines of any origin with unknown status of p53.
- Published
- 2003
- Full Text
- View/download PDF
13. Activation of Akt/Protein Kinase B Overcomes a G2/M Cell Cycle Checkpoint Induced by DNA Damage
- Author
-
Pier Paolo Pandolfi, Nathan Majewski, Antonio Di Cristofano, Claudine S. Feliciano, Eugene S. Kandel, Jennifer E. Skeen, Nissim Hay, and Andrei L. Gartel
- Subjects
Cell cycle checkpoint ,DNA Repair ,Recombinant Fusion Proteins ,AKT1 ,Protein Serine-Threonine Kinases ,Biology ,Cell Line ,Proto-Oncogene Proteins c-myc ,Mice ,Phosphatidylinositol 3-Kinases ,Proto-Oncogene Proteins ,CDC2 Protein Kinase ,Animals ,Humans ,Genes, Tumor Suppressor ,CHEK1 ,Cell Growth and Development ,Molecular Biology ,Protein kinase B ,PI3K/AKT/mTOR pathway ,Cyclin-dependent kinase 1 ,Stem Cells ,Tumor Suppressor Proteins ,Cell Cycle ,PTEN Phosphohydrolase ,Cell Biology ,Cell cycle ,G2-M DNA damage checkpoint ,Molecular biology ,Phosphoric Monoester Hydrolases ,Rats ,Enzyme Activation ,Genes, cdc ,Proto-Oncogene Proteins c-bcl-2 ,Gamma Rays ,Tumor Suppressor Protein p53 ,Proto-Oncogene Proteins c-akt ,DNA Damage ,Signal Transduction - Abstract
Activation of Akt, or protein kinase B, is frequently observed in human cancers. Here we report that Akt activation via overexpression of a constitutively active form or via the loss of PTEN can overcome a G(2)/M cell cycle checkpoint that is induced by DNA damage. Activated Akt also alleviates the reduction in CDC2 activity and mitotic index upon exposure to DNA damage. In addition, we found that PTEN null embryonic stem (ES) cells transit faster from the G(2)/M to the G(1) phase of the cell cycle when compared to wild-type ES cells and that inhibition of phosphoinositol-3-kinase (PI3K) in HEK293 cells elicits G(2) arrest that is alleviated by activated Akt. Furthermore, the transition from the G(2)/M to the G(1) phase of the cell cycle in Akt1 null mouse embryo fibroblasts (MEFs) is attenuated when compared to that of wild-type MEFs. These results indicate that the PI3K/PTEN/Akt pathway plays a role in the regulation of G(2)/M transition. Thus, cells expressing activated Akt continue to divide, without being eliminated by apoptosis, in the presence of continuous exposure to mutagen and accumulate mutations, as measured by inactivation of an exogenously expressed herpes simplex virus thymidine kinase (HSV-tk) gene. This phenotype is independent of p53 status and cannot be reproduced by overexpression of Bcl-2 or Myc and Bcl-2 but seems to counteract a cell cycle checkpoint mediated by DNA mismatch repair (MMR). Accordingly, restoration of the G(2)/M cell cycle checkpoint and apoptosis in MMR-deficient cells, through reintroduction of the missing component of MMR, is alleviated by activated Akt. We suggest that this new activity of Akt in conjunction with its antiapoptotic activity may contribute to genetic instability and could explain its frequent activation in human cancers.
- Published
- 2002
- Full Text
- View/download PDF
14. Solubility Studies and Synthesis of Acpheleunh2in Reversed Micellar Systems
- Author
-
Ana S. Feliciano, Duarte M. F. Prazeres, and Joaquim M. S. Cabral
- Subjects
Octanol ,Heptane ,Molar concentration ,Dipeptide ,Inorganic chemistry ,Biochemistry ,Micelle ,Catalysis ,chemistry.chemical_compound ,chemistry ,Pulmonary surfactant ,Micellar solutions ,Organic chemistry ,lipids (amino acids, peptides, and proteins) ,Solubility ,Biotechnology - Abstract
The aim of the work presented was to study the precipitation of the dipeptide derivative AcPheLeuNH2 in order to improve its yield and productivity during enzymatic synthesis catalysed by α-chymotrypsin in tetradecyltrimethylammonium bromide (TTAB)/heptane/octanol reversed micelles. AcPheLeuNH2 solubility in reversed micellar solutions was examined, revealing that a decrease in TTAB concentration, water to surfactant ratio (Wao) and octanol concentration in the organic mixture led to a decrease in solubility. In contrast, no significant influence of buffer molarity and pH was detected. These results were explained by suggesting that the main environment for the solubilization of the dipeptide molecules is the micellar interface rather than the bulk organic phase or the micellar water pool. The synthesis of AcPheLeuNH2 was then carried out using those process conditions that led to the lower solubility values. The activity and stability of α-chymotrypsin, dipeptide yield, selectivity, dipeptide recovery an...
- Published
- 1996
- Full Text
- View/download PDF
15. DEVELOPMENT AND CHARACTERIZATION OF A FLUORESCENT WHOLE-CELL BIOSENSOR FOR L-ARABINOSE WITH INTERNAL RESPONSE CORRECTION USING TWO GFP MUTANTS
- Author
-
M Mirasoli, E Michelini, A Roda, J S Feliciano-Cardona, and S Daunert
- Subjects
Biochemistry ,L-Arabinose ,Chemistry ,Mutant ,Internal response ,Whole cell ,Fluorescence ,Biosensor ,Green fluorescent protein - Published
- 2002
- Full Text
- View/download PDF
16. [Functional capacity after heart transplantation]
- Author
-
M, Mendes, L, Brízida, M J, Rebocho, L, Bronze, S, Feliciano, J, Queiroz e Melo, and R, Seabra-Gomes
- Subjects
Adult ,Male ,Exercise Test ,Heart Transplantation ,Humans ,Female ,Middle Aged - Published
- 1998
17. An HSVtk-mediated local and distant antitumor bystander effect in tumors of head and neck origin in athymic mice
- Author
-
W, Bi, Y G, Kim, E S, Feliciano, L, Pavelic, K M, Wilson, Z P, Pavelic, and P J, Stambrook
- Subjects
Mice ,Head and Neck Neoplasms ,Genetic Vectors ,Animals ,Humans ,Mice, Nude ,Simplexvirus ,3T3 Cells ,Genetic Therapy ,Mice, SCID ,Neoplasms, Experimental ,Thymidine Kinase - Abstract
The "bystander effect," produced by ganciclovir-mediated killing of cells transduced with a herpes simplex virus thymidine kinase (HSVtk) gene, defines the cooperative killing of non-HSVtk-transduced cells. In vitro, a major contributor to this phenomenon is metabolic cooperation involving transfer of cytotoxic small molecules between cells via gap junctions. In this study, the bystander effect was assessed in vivo using cells of oral squamous cell carcinoma origin. Mixtures of HSVtk+ and HSVtk- tumor cells were implanted subcutaneously in the left flank of nude mice, and naive HSVtk- cells were implanted subcutaneously in the right flank. When tumors attained a size of 0.5 to 1 cm, the animals were treated with ganciclovir on a daily basis. The tumors comprised of mixed cells in the left flank resolved, consistent with a predicted bystander effect. The naive tumors in the right flank either resolved or became cytostatic showing little further growth compared to controls. Similar results were obtained when naive tumors were grown in both flanks and the tumor in the left flank received intratumoral injection of HSVtk retroviral producer cells or PA317 (HSVtk+) packaging cells, but not parental NIH 3T3 cells. Concomitant treatment with dexamethasone impaired the antitumor effect on the contralateral side. When these experiments were performed in SCID-Beige mice, there was a reduced antitumor effect on the ipsilateral flank and no antitumor response in the contralateral flank. Together with histology of regressing tumors, which showed an infiltration of lymphoid cells, these results are suggestive of an immune-related antitumor response that could account for the distant bystander effect.
- Published
- 1997
18. [Prevalence of late potentials in coronary patients with and without a history of myocardial infarction]
- Author
-
S, Feliciano, C, Reis, F, Mesquita, A, Monteiro, and A, Barbaça
- Subjects
Male ,Myocardial Infarction ,Humans ,Coronary Disease ,Female ,Middle Aged ,Evoked Potentials - Published
- 1997
19. Determining requirements for case management in long-term health care
- Author
-
M S, Feliciano
- Subjects
Patient Care Team ,Health Services Needs and Demand ,Humans ,Continuity of Patient Care ,Community Health Nursing ,Long-Term Care ,Patient Care Planning ,United States ,Aged - Published
- 1996
20. [A multivariate analysis approach to antineoplastic and antiviral structure-activity relationships to a series of podophyllotoxins]
- Author
-
J C, Doré, C, Viel, N, Pageot, M, Gordaliza, A, Castro, J M, del Corral, and A S, Feliciano
- Subjects
Structure-Activity Relationship ,Multivariate Analysis ,Tumor Cells, Cultured ,Animals ,Humans ,Drug Screening Assays, Antitumor ,Antineoplastic Agents, Phytogenic ,Antiviral Agents ,Podophyllotoxin - Abstract
In this work, the authors have used technics of multivariate analysis to determine the structure-activity relationships of 46 podophyllotoxin derivatives and analogs studied for their antineoplastic and antiviral activities. The obtained results allow to envisage the possible synthesis of more specific molecules by making modifications in the structure of the model molecular archetype.
- Published
- 1996
21. Seasonal and geographical variations in the growth rate of infants in China receiving increasing dosages of vitamin D supplements
- Author
-
Qing-mei Shui, Tai-an Yin, Grace A. Falciglia, Mona L. Ho, Bonny Specker, E. S. Feliciano, and Xue-cun Chen
- Subjects
China ,Dose ,Season of birth ,Growth ,Chine ,Vitamin D and neurology ,Medicine ,Humans ,Growth rate ,Vitamin D ,Geographic difference ,Sunlight ,Anthropometry ,Dose-Response Relationship, Drug ,business.industry ,Body Weight ,Infant, Newborn ,Infant ,Chinese people ,Body Height ,Infectious Diseases ,Pediatrics, Perinatology and Child Health ,Food, Fortified ,Seasons ,business ,Demography - Abstract
In theory, sunshine exposure is sufficient to maintain normal vitamin D concentrations for the optimal growth of newborn infants. To determine whether season of birth, latitude (north v. south) and increasing dosages of vitamin D supplements would influence the growth rate for the first 6 months of life, 255 healthy fall-and spring-born infants from two northern and two southern cities in China were randomly assigned to receive either 100, 200, or 400 IU of vitamin D a day. The study showed that season of birth and dose of vitamin D did not affect the growth rate of infants born in the same latitude, but a significant difference was found in the gain in length over the 6-month period between infants from the north and infants from the south (P = 0.0001). Regional differences among the Chinese people, other than sunshine exposure, may have influenced the difference in length gain.
- Published
- 1994
22. Repeated-batch cultures of Baby Hamster Kidney cell aggregates in stirred vessels
- Author
-
J. L. Moreira, A. S. Feliciano, P. C. Santana, P. E. Cruz, J. G. Aunins, and M. J. T. Carrondo
- Published
- 1994
- Full Text
- View/download PDF
23. Attenuated heart rate recovery is a strong predictor of mortality in patients with left ventricular systolic dysfunction
- Author
-
P. Carmo, M Mendes, Carlos Aguiar, S. Feliciano, António Ferreira, and Aurora Futuro Silva
- Subjects
medicine.medical_specialty ,business.industry ,Internal medicine ,Heart rate ,medicine ,Cardiology ,In patient ,Cardiology and Cardiovascular Medicine ,business - Published
- 2008
- Full Text
- View/download PDF
24. Initial therapeutic strategy in follicular lymphoma (FL): An analysis from the National LymphoCare Study (NLCS)
- Author
-
Jonathan W. Friedberg, John D. Hainsworth, R. Steis, Brian K. Link, J. Huang, S. Feliciano, Charles M. Farber, Hildy Dillon, Andrew D. Zelenetz, and Julie M. Vose
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Pathology ,Chemotherapy ,business.industry ,medicine.medical_treatment ,Follicular lymphoma ,medicine.disease ,Internal medicine ,medicine ,Initial treatment ,Rituximab ,business ,Initial therapy ,Therapeutic strategy ,medicine.drug - Abstract
7527 Background: Initial treatment strategies in FL include observation (obs), rituximab (R), chemotherapy ± R, and XRT. A recent study suggests initial therapy may impact FL survival (JCO 23:8447). NLCS is the first prospective observational study in the US designed to assess FL presentation, prognosis, treatment, and clinical outcomes. We describe initial therapeutic strategy in NLCS FL pts. Methods: FL pts diagnosed within 6 months with no prior lymphomas were recruited in this ongoing study. Data collected includes histology, stage, therapy, response, relapse and death. There is no specified treatment regimen. Results: From 3/04 to 11/05 1493 pts enrolled at 237 sites in the United States. Demographics have been initially reported at ASH 2005 (Blood 106:293a) and are comparable to SEER. Initial therapeutic strategy was: obs, 19%; R-monotherapy, 13%; chemo+R, 51%; XRT, 5%; chemo only, 4%. Chemo+R regimens were: R-CHOP, 59%; R-CVP, 19%; R-fludarabine based,11%; other, 11%. Choice to initiate therapy was associated with FLIPI, stage, and grade (p < 0.0001). Significant regional differences (p < 0.0001) were noted: obs was used in 13% of pts in Southeast and 31% in Northeast (NE); fludarabine-based R-chemo was used in 18% of pts in Southwest and only 3% in NE. Academic sites were more likely than community sites to treat pts on clinical trials (12% vs 4%). In pts treated with R or chemo+R, a higher FLIPI was not associated with decision to utilize chemotherapy. 26% of initially observed pts have switched to active therapy after a median of 2.8 months on obs since diagnosis; this was associated with baseline grade (III>II>I), but not stage or FLIPI. Conclusions: Diverse regimens are used for initial management of FL in the United States. Few pts are treated on clinical trials. Significant differences among regions and between center types suggest physician preference may drive initial therapy. Studies such as NLCS are needed to better understand the impact of initial therapy on short- and long-term outcomes. [Table: see text]
- Published
- 2006
- Full Text
- View/download PDF
25. Law, Gender, and the Family in the Philippines
- Author
-
Myrna S. Feliciano
- Subjects
Sociology and Political Science ,Ethnology ,Sociology ,Law ,Humanities - Abstract
L'A. retrace les changements de statut social et juridique des femmes philippines en examinant l'evolution de l'heritage juridique et colonial philippin a partir de l'immigration des Malays musulmans au XIV e siecle jusqu'a nos jours. L'A. demontre que les femmes beneficiaient d'un rang social eleve, dans ce qui est desormais la Republique des Philippines, jusqu'a la colonisation par l'Espagne au XVII e siecle, date a laquelle les coutumes, la religion et le droit espagnols ont impose de nombreuses restrictions sur les femmes. Il faut attendre l'instauration de la Republique en 1946 pour que des efforts commencent a renverser ces politiques restrictives. L'A. insiste particulierement sur la Constitution de 1986 et les changements operes dans le Code de la famille, qui ont mis en valeur l'egalite juridique des femmes au sein de la famille. L'A. appuie sur le fait qu'un travail politique doit etre soutenu pour assurer une application des lois existantes et poursuivre les changements juridiques en faveur des femmes
- Published
- 1994
- Full Text
- View/download PDF
26. Law Libraries and Legal Documentation in the Philippines
- Author
-
Myrna S. Feliciano
- Subjects
Documentation ,Political science ,Law - Abstract
The Philippines, an archipelago of 7,107 islands, (about 2,000 of which are inhabited) with a land area of 115,600 square miles, has a population of 42 million. Some 87 major dialects are spoken all over the islands. English and Filipino are the official languages with English as the medium of instruction in higher education. According to the latest census, the literacy rate is 83.4 per cent. Agriculture constitutes the largest single sector of the economy. The Philippines has a total labor force of 14.2 million.Filipino culture is a blend of East and West, although foundationally and originally Malay. Its Eastern heritage – the result of centuries of interaction with neighboring countries of Asia – is a synthesis of three mainstreams: the Malay, Chinese and Hindu. Its Western cultural traits are the result of her colonization by two Western powers: Spain and the United States.
- Published
- 1976
- Full Text
- View/download PDF
27. Human Rights Documentation
- Author
-
Myrna S. Feliciano
- Subjects
Documentation ,Human rights ,Political science ,Law ,media_common.quotation_subject ,General Medicine ,media_common - Abstract
Studies on international human rights had amorphous beginnings before 1945, which gradually evolved into an intricate but “untrodden area of systematic research.” This is largely attributed to the adoption of the United Nations Charter which sets forth the international protection of human rights as a basic purpose. The proclamation of the Universal Declaration of Human Rights by the United Nations General Assembly in December 10, 1948, provided the impetus for the development of new rules of international law defining in specific terms, individual rights and freedoms. The result is not only a substantial and rapidly developing body of law, both substantive and procedural, that has called for a systematic scholarly analysis but a bibliographic output on the subject which has reached alarming proportions to what is now being referred to as “the human rights documentation explosion.”
- Published
- 1981
- Full Text
- View/download PDF
28. Current Legal Research in the Philippines
- Author
-
Myrna S. Feliciano
- Subjects
Legal research ,Political science ,Law ,Current (fluid) - Abstract
Legal research traditionally has been concerned with the development or elaboration of legal doctrines, and the raw materials of such research have been statutes, administrative regulations and rulings, and court decisions. This type of research is termed as doctrinal research. Characteristically, a legal scholar undertaking doctrinal research takes one or more legal propositions as a starting point and focus of his study. Research then takes place in the law library, where the scholar tries to locate all relevant statutes, cases and all discussions of his proposition found in encyclopedias, textbooks, treatises, and legal periodicals. If the legal concept is taken from a statute, his sources would necessarily include the statute, its legislative history and, if possible, comparable statutes in other jurisdictions. He then analyzes his readings, formulates his conclusions and writes up his study in the form of a memorandum, a brief, a periodical article or a treatise.
- Published
- 1979
- Full Text
- View/download PDF
29. [Computerization of the operating room service in the department of plastic surgery at the San Camillo Hospital]
- Author
-
P, Caldani, M, Eleuteri, F, Moscati, L, Elia, and S, Feliciano
- Subjects
Operating Rooms ,Italy ,Hospital Departments ,Humans ,Surgery, Plastic ,Surgery Department, Hospital ,Medical Records ,Software - Published
- 1988
30. Cytochemical observation of regulated bacterial beta-galactosidase gene expression in mammalian cells
- Author
-
Peter J. Stambrook, Estrella S. Feliciano, and Hsiao Sheng Liu
- Subjects
Transcription, Genetic ,Genetic Vectors ,lac operon ,Biology ,Lac repressor ,Transfection ,Gene Expression Regulation, Enzymologic ,Cell Line ,Gene product ,Plasmid ,Gene expression ,Animals ,Humans ,Northern blot ,Gene ,Multidisciplinary ,Blotting, Northern ,beta-Galactosidase ,Molecular biology ,Galactosidases ,RNA, Bacterial ,Genes, Bacterial ,Enzyme Induction ,Enzyme Repression ,Research Article - Abstract
Bacterial beta-galactosidase, encoded by the lacZ gene, serves as a sensitive cytochemical marker in eukaryotic cells and tissues. In transient expression experiments, human and simian cells stain blue 48 hr after transfection with a plasmid containing a lacZ gene, whose expression is directed by a simian virus 40 promoter containing a synthetic lactose operator sequence. Transfection efficiency was about 0.6%. Incorporation of an operator sequence within the promoter permits regulation of beta-galactosidase gene expression by the lacI gene product, the lac repressor. When cells were cotransfected with the lacZ plasmid and a second plasmid containing the lacI gene, beta-galactosidase activity was extinguished. Its activity could be reestablished to original levels upon application of isopropyl beta-D-thiogalactoside to transfected cells. A cell line that stably carries both the lacI and lacZ genes was efficiently induced to synthesize beta-galactosidase after isopropyl beta-D-thiogalactoside administration. In transient expression experiments and in stably transfected lines, repression and induction of beta-galactosidase activity were predominantly at the transcriptional level.
- Published
- 1989
31. [Reconstruction of the breast after radical mastectomy in cancer. Reconstruction of the breast volume]
- Author
-
L, Elia, M, Eleuteri, S, Feliciano, P, Serafini, and M, Marcasciano
- Subjects
Humans ,Breast Neoplasms ,Female ,Breast ,Surgery, Plastic ,Mastectomy, Radical ,Surgical Flaps - Abstract
After underlining the serious psychological consequences of radical mastectomy for carcinoma and the importance of breast reconstruction for the patient's complete recovery, the paper briefly reviews the main reconstruction techniques employed in restoring breast volume which is essentially achieved by inserting an artificial prosthesis below a myocutaneous skin flap often taken from the great dorsal. Some mention is also made of recently developed alternative techniques.
- Published
- 1989
32. [Filling materials in the repair and esthetic surgery of the breast. Historical notes]
- Author
-
L, Elia, S, Feliciano, M, Eleuteri, P, Serafini, and M, Marcasciano
- Subjects
Humans ,Female ,Breast ,Prostheses and Implants ,History, 20th Century ,Surgery, Plastic - Abstract
The biological and synthetic materials employed over the years for filling breasts after mastectomy or for congenital malformations are reviewed. At the start of the century, breast shape and volume were changed by adipose tissue grafts. In the 50s and 60s dermo-fibro-adipose grafts and later auto-grafts and grafts of the large epiploon were used. Synthetic materials have also developed, from early century attempts using paraffin injections to the discovery for industrial use of plastics. Following the first polyvinyl prostheses, Cronin developed silicon prostheses for medical purposes and in later years these went through numerous changes in form, volume and design up to the recent skin expanders. Polyurethane has also been used in attempts to reduce capsular retraction.
- Published
- 1989
33. [Reconstruction of the breast after radical mastectomy in cancer. Reconstruction of the areola-nipple complex and the symmetry of the 2 breasts]
- Author
-
L, Elia, S, Feliciano, M, Eleuteri, P, Serafini, and M, Marcasciano
- Subjects
Esthetics ,Nipples ,Humans ,Breast Neoplasms ,Female ,Breast ,Prostheses and Implants ,Mastectomy, Radical ,Surgical Flaps - Abstract
After pointing out the need for reconstruction of the nipple-areola complex and the restoration of symmetry between the two breasts after radical mastectomy for cancer, the paper briefly examines the techniques currently available for the achievement of these "finishing touches" that usually take longer then the primary and fundamental breast reconstruction.
- Published
- 1989
34. [Conservative surgery and esthetic rehabilitation of carcinoma of the breast]
- Author
-
L, Elia, F, Moscati, S, Feliciano, M, Eleuteri, and P, Serafini
- Subjects
Humans ,Breast Neoplasms ,Female ,Breast ,Surgery, Plastic ,Mastectomy - Abstract
A careful review of the literature stimulated these comments on current developments in conservative surgery as an alternative to radical mastectomy in stage I and II breast cancer with particular reference to their implications for cosmetic rehabilitation. It is emphasised that the data so far available indicate comparable results in terms of locoregional recurrences, metastases and survival. It is also pointed out that the efficacy of the conservative techniques reflects new concepts of the natural history of breast cancer. The hope is expressed that these encouraging data will be confirmed by more extensive and systematic clinical experiment in order to minimise the indications to more radical surgery which notoriously has such devastating physical and psychological effects that it takes extremely complex and demanding plastic surgery to reshape the patient to psychological sexual and social health.
- Published
- 1989
35. [Treatment of fractures of the mandible: a new type of external fixator]
- Author
-
P, Caldani, M, Eleuteri, S, Feliciano, and L, Elia
- Subjects
Adult ,Male ,Orthotic Devices ,Fracture Fixation ,Mandibular Fractures ,Humans - Abstract
The use of external fixators in the treatment of complex mandibular fractures is described, as are the advantages offered by the technique which permits accurate, controlled reduction of the bone fragment without immobilising the temporomandibular joint.
- Published
- 1989
36. [Use of skin expansion in reconstructive skin surgery]
- Author
-
F, Moscati, M, Eleuteri, M, Massarelli, and S, Feliciano
- Subjects
Preoperative Care ,Methods ,Humans ,Surgery, Plastic ,Surgical Flaps - Published
- 1988
37. [Complications of septorhinoplasty]
- Author
-
L, Elia, F, Moscati, A, Belli, M, Marcasciano, S, Feliciano, M, Eleuteri, L, Puccio, and M, Elia
- Subjects
Postoperative Complications ,Humans ,Rhinoplasty ,Nasal Septum - Abstract
A review of the literature on complications in septorhinoplasty is presented. Though rare, complications may arise in the surgical treatment of such a delicate anatomical area as the nasal septum and both theoretical and practical knowledge of the problem is necessary in order to prevent and/or handle such unexpected events. Complications are grouped according to aetiopathogenesis into infectious, haemorrhagic, traumatic, systemic and miscellaneous.
- Published
- 1989
38. [Development of the surgical technics in abdominoplasty]
- Author
-
L, Elia, S, Feliciano, M, Eleuteri, P, Serafini, and M, Marcasciano
- Subjects
Lipectomy ,Humans ,History, 19th Century ,History, 20th Century ,Abdominal Muscles - Abstract
The entire literature on abdominoplasty is reviewed with a description of the various techniques developed since the introduction of the operation.
- Published
- 1989
39. [Treatment of tissue loss in surgery of the scalp. An analysis of 89 patients brought to our attention]
- Author
-
L, Elia, F, Moscati, M, Eleuteri, and S, Feliciano
- Subjects
Adult ,Male ,Scalp ,Skin Neoplasms ,Adolescent ,Esthetics ,Humans ,Female ,Middle Aged ,Surgical Flaps ,Aged - Abstract
The recent computerisation of operating theatre and forensic files facilitated a retrospective study of 136 plastic surgery operations performed on 89 patients presenting traumatic or surgical scalp tissue loss in the San Camillo Hospital, Rome between 1/1/1980 and 31/12/1987. The study provided some useful data for the planning of the surgical approach to this delicate anatomical area. Where the dimensions of the defect and the trophic condition of the local tissues permitted, the best functional and cosmetic results were obtained by using flaps of contiguous skin. In this field, new prospects are offered by the introduction of skin expanders whose gradual and controlled distension of the skin permit excellent functional and cosmetic results.
- Published
- 1989
40. Philippine Law and Jurisprudence, v. 1—November/December, 1977—Manila Current Events Digest, Inc., 1978—v. (3 volumes published so far)
- Author
-
Myrna S. Feliciano
- Subjects
Political science ,Jurisprudence ,Law ,Current (fluid) - Published
- 1980
- Full Text
- View/download PDF
41. The Administration, Adjudication and Enforcement of Labor Justice in the Philippines. Geronimo Q. Quadra. Manila, Rex Book Store, 1979. 661 pp
- Author
-
Myrna S. Feliciano
- Subjects
Political science ,Law ,Enforcement ,Administration (government) ,Economic Justice ,Adjudication - Published
- 1980
- Full Text
- View/download PDF
42. Comparison of diagnostic accuracy of rapid antigen tests for COVID-19 compared to the viral genetic test in adults: a systematic review and meta-analysis.
- Author
-
Hirabayashi E, Mercado G, Hull B, Soin S, Koshy-Chenthittayil S, Raman S, Huang T, Keerthisinghe C, Feliciano S, Dongo A, Kal J, Azizan A, Duus K, Else T, DeArmond M, and Stone AEL
- Subjects
- Adult, Humans, Antigens, Viral isolation & purification, COVID-19 Nucleic Acid Testing methods, COVID-19 Serological Testing methods, Sensitivity and Specificity, Rapid Diagnostic Tests, COVID-19 diagnosis, COVID-19 immunology, COVID-19 virology, SARS-CoV-2 genetics, SARS-CoV-2 immunology, SARS-CoV-2 isolation & purification
- Abstract
Objective: The objective of this review was to determine the diagnostic accuracy of the currently available and upcoming point-of-care rapid antigen tests (RATs) used in primary care settings relative to the viral genetic real-time reverse transcriptase polymerase chain reaction (RT-PCR) test as a reference for diagnosing COVID-19/SARS-CoV-2 in adults., Introduction: Accurate COVID-19 point-of-care diagnostic tests are required for real-time identification of SARS-CoV-2 infection in individuals. Real-time RT-PCR is the accepted gold standard for diagnostic testing, requiring technical expertise and expensive equipment that are unavailable in most primary care locations. RATs are immunoassays that detect the presence of a specific viral protein, which implies a current infection with SARS-CoV-2. RATs are qualitative or semi-quantitative diagnostics that lack thresholds that provide a result within a short time frame, typically within the hour following sample collection. In this systematic review, we synthesized the current evidence regarding the accuracy of RATs for detecting SARS-CoV-2 compared with RT-PCR., Inclusion Criteria: Studies that included nonpregnant adults (18 years or older) with suspected SARS-CoV-2 infection, regardless of symptomology or disease severity, were included. The index test was any available SARS-CoV-2 point-of-care RAT. The reference test was any commercially distributed RT-PCR-based test that detects the RNA genome of SARS-CoV-2 and has been validated by an independent third party. Custom or in-house RT-PCR tests were also considered, with appropriate validation documentation. The diagnosis of interest was COVID-19 disease and SARS-CoV-2 infection. This review considered cross-sectional and cohort studies that examined the diagnostic accuracy of COVID-19/SARS-CoV-2 infection where the participants had both index and reference tests performed., Methods: The keywords and index terms contained in relevant articles were used to develop a full search strategy for PubMed and adapted for Embase, Scopus, Qinsight, and the WHO COVID-19 databases. Studies published from November 2019 to July 12, 2022, were included, as SARS-CoV-2 emerged in late 2019 and is the cause of a continuing pandemic. Studies that met the inclusion criteria were critically appraised using QUADAS-2. Using a customized tool, data were extracted from included studies and were verified prior to analysis. The pooled sensitivity, specificity, positive predictive, and negative predictive values were calculated and presented with 95% CIs. When heterogeneity was observed, outlier analysis was conducted, and the results were generated by removing outliers., Results: Meta-analysis was performed on 91 studies of 581 full-text articles retrieved that provided true-positive, true-negative, false-positive, and false-negative values. RATs can identify individuals who have COVID-19 with high reliability (positive predictive value 97.7%; negative predictive value 95.2%) when considering overall performance. However, the lower level of sensitivity (67.1%) suggests that negative test results likely need to be retested through an additional method., Conclusions: Most reported RAT brands had only a few studies comparing their performance with RT-PCR. Overall, a positive RAT result is an excellent predictor of a positive diagnosis of COVID-19. We recommend that Roche's SARS-CoV-2 Rapid Antigen Test and Abbott's BinaxNOW tests be used in primary care settings, with the understanding that negative results need to be confirmed through RT-PCR. We recommend adherence to the STARD guidelines when reporting on diagnostic data., Review Registration: PROSPERO CRD42020224250., Competing Interests: The authors declare no conflicts of interest., (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on Behalf of JBI.)
- Published
- 2024
- Full Text
- View/download PDF
43. [Efficacy of sacituzumab govitecan in a patient with TNBC with early relapse after neoadjuvant chemotherapy.]
- Author
-
Carlino F and Feliciano S
- Subjects
- Humans, Female, Adult, Quality of Life, Treatment Outcome, Antibodies, Bispecific administration & dosage, Camptothecin analogs & derivatives, Camptothecin administration & dosage, Immunoconjugates, Triple Negative Breast Neoplasms drug therapy, Triple Negative Breast Neoplasms pathology, Neoadjuvant Therapy methods, Antibodies, Monoclonal, Humanized administration & dosage, Antibodies, Monoclonal, Humanized therapeutic use, Neoplasm Recurrence, Local drug therapy
- Abstract
Triple-negative breast cancers patients who relapse within 12 months from the end of neoaadjuvant chemotherapy represent a subgroup with a particularly poor prognosis, due to resistance to common chemotherapy treatments. Therefore, innovative therapeutic strategies are necessary for these patients. The therapeutic arsenal for triple-negative breast cancer has been enriched in recent years with new drugs, including antibody-drug conjugates. Sacituzumab govitecan, the first antibody directed against Trop-2, has been shown to improve survival in triple-negative metastatic breast cancer (the most aggressive subtype of breast cancer) in women who have received at least two prior chemotherapy treatments in the metastatic setting. This drug has demonstrated its effectiveness even in patients with early relapse after neoadjuvant treatment. In this clinical case we describe the story of a young patient with triple-negative breast cancer, with lymphnodal recurrence, who relapses within the first 12 months after the end of neoadjuvant chemotherapy. Sacituzumab govitecan resulted in a rapid and impressive clinical and instrumental response, associated with an improvement in quality of life and excellent functional status during therapy.
- Published
- 2024
- Full Text
- View/download PDF
44. Good Manufacturing Practice-compliant change of raw material in the manufacturing process of a clinically used advanced therapy medicinal product-a comparability study.
- Author
-
Wixmerten A, Miot S, Bittorf P, Wolf F, Feliciano S, Hackenberg S, Häusner S, Krenger W, Haug M, Martin I, Pullig O, and Barbero A
- Subjects
- Humans, Karyotyping, Knee Joint, Chondrocytes, Tissue Engineering
- Abstract
The development of medicinal products often continues throughout the different phases of a clinical study and may require challenging changes in raw and starting materials at later stages. Comparability between the product properties pre- and post-change thus needs to be ensured. Here, we describe and validate the regulatory compliant change of a raw material using the example of a nasal chondrocyte tissue-engineered cartilage (N-TEC) product, initially developed for treatment of confined knee cartilage lesions. Scaling up the size of N-TEC as required for the treatment of larger osteoarthritis defects required the substitution of autologous serum with a clinical-grade human platelet lysate (hPL) to achieve greater cell numbers necessary for the manufacturing of larger size grafts. A risk-based approach was performed to fulfill regulatory requirements and demonstrate comparability of the products manufactured with the standard process (autologous serum) already applied in clinical indications and the modified process (hPL). Critical attributes with regard to quality, purity, efficacy, safety and stability of the product as well as associated test methods and acceptance criteria were defined. Results showed that hPL added during the expansion phase of nasal chondrocytes enhances proliferation rate, population doublings and cell numbers at passage 2 without promoting the overgrowth of potentially contaminant perichondrial cells. N-TEC generated with the modified versus standard process contained similar content of DNA and cartilaginous matrix proteins with even greater expression levels of chondrogenic genes. The increased risk for tumorigenicity potentially associated with the use of hPL was assessed through karyotyping of chondrocytes at passage 4, revealing no chromosomal changes. Moreover, the shelf-life of N-TEC established for the standard process could be confirmed with the modified process. In conclusion, we demonstrated the introduction of hPL in the manufacturing process of a tissue engineered product, already used in a late-stage clinical trial. Based on this study, the national competent authorities in Switzerland and Germany accepted the modified process which is now applied for ongoing clinical tests of N-TEC. The described activities can thus be taken as a paradigm for successful and regulatory compliant demonstration of comparability in advanced therapy medicinal products manufacturing., (Copyright © 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
45. HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study.
- Author
-
Carlino F, Diana A, Ventriglia A, Piccolo A, Mocerino C, Riccardi F, Bilancia D, Giotta F, Antoniol G, Famiglietti V, Feliciano S, Cangiano R, Lobianco L, Pellegrino B, De Vita F, Ciardiello F, and Orditura M
- Abstract
Background: Approximately 45-50% of breast cancers (BCs) have a HER2 immunohistochemical score of 1+ or 2+ with negative in situ hybridization, defining the "HER2-low BC" subtype. No anti-HER2 agents are currently approved for this subgroup in Europe, where treatment is still determined by HR expression status. In this study, we investigated the prognostic significance of HER2-low status in HR+/HER2- metastatic BC (MBC) patients treated with endocrine therapy (ET) plus palbociclib as first line., Methods: We conducted a retrospective study including 252 consecutive HR+/HER2- MBC patients who received first-line ET plus palbociclib at six Italian Oncology Units between March 2016 and June 2021. The chi-square test was used to assess differences in the distribution of clinical and pathological variables between the HER-0 and HER2-low subgroups. Survival outcomes, progression-free survival (PFS) and overall survival (OS), were calculated by the Kaplan-Meier method, and the log-rank test was performed to estimate the differences between the curves., Results: A total of 165 patients were included in the analysis: 94 (57%) and 71 (43%) patients had HER2-0 and HER2-low disease, respectively. The median age at treatment start was 64 years. No correlation between patients and tumor characteristics and HER2 status was found. Median PFS (mPFS) for the entire study cohort was 20 months (95% CI,18-25 months), while median OS (mOS) was not reached at the time of analysis. No statistically significant differences, in terms of PFS ( p = 0.20) and OS ( p = 0.1), were observed between HER2-low and HER2-0 subgroups., Conclusions: In our analysis, HR+ MBC patients with low HER2 expression who received first-line treatment with ET plus Palbociclib reported no statistically different survival outcomes compared to HER2-0 patients. Further prospective studies are needed to confirm the clinical role of HER2 expression level.
- Published
- 2022
- Full Text
- View/download PDF
46. Comparison of Human Articular Cartilage Tissue and Chondrocytes Isolated from Peripheral versus Central Regions of Traumatic Lesions.
- Author
-
Acevedo L, Iselin L, Berkelaar MHM, Salzmann GM, Wolf F, Feliciano S, Vogel N, Pagenstert G, Martin I, Pelttari K, Barbero A, and Arnold MP
- Subjects
- Aggrecans metabolism, Cell Differentiation genetics, Chondrogenesis, Humans, Cartilage, Articular, Chondrocytes metabolism
- Abstract
Objective: Cellular and molecular events occurring in cartilage regions close to injury are poorly investigated, but can possibly compromise the outcome of cell-based cartilage repair. In this study, key functional properties were assessed for cartilage biopsies collected from the central part of traumatic joint lesions ( central ) and from regions surrounding the defect ( peripheral ). These properties were then correlated with the quality of the initial cartilage biopsy and the inflammatory state of the joint., Design: Cartilage samples were collected from knee joints of 42 patients with traumatic knee injuries and analyzed for cell phenotype (by reverse transcriptas-polymerase chain reaction), histological quality, cellularity, cell viability, proliferation capacity, and post-expansion chondrogenic capacity of chondrocytes (in pellet culture). Synovium was also harvested and analyzed for the expression of inflammatory cytokines., Results: Cartilage quality and post-expansion chondrogenic capacity were higher in peripheral versus central samples. Differences between these 2 parameters were more pronounced in joints with high inflammatory features characterized by >100-fold difference in the mRNA levels of IL6 and IL8 in the corresponding synovium. Peripheral chondrocytes isolated from good- versus bad-quality biopsies expressed higher levels of collagen II/I and aggrecan/versican and lower levels of MMP13 and ADAMTS5. They also exhibited reduced proliferation and enhanced cartilage-forming capacity., Conclusions: Chondrocytes at the periphery of traumatic lesions better maintain properties of healthy cartilage compared to those isolated from the center, even when derived from bad-quality tissues harvested from highly inflamed joints. Future studies are necessary to investigate the change of functional properties of peripheral chondrocytes over time.
- Published
- 2021
- Full Text
- View/download PDF
47. Perceptions and Preferences Regarding Multiple Sclerosis Research Among Racial and Ethnic Groups.
- Author
-
Pimentel Maldonado DA, Moreno A, Williams MJ, Amezcua L, Feliciano S, Williams A, Machemer D, Livingston T, LaRocque M, Glim M, and Schmidt H
- Abstract
Background: For unclear reasons, minorities have been historically underrepresented in multiple sclerosis (MS) clinical trials. We hypothesized that different perceptions and preferences about research participation among racial and ethnic groups contribute to this imbalance., Methods: Members of the MS Minority Research Engagement Partnership Network developed a Web-based survey in English and Spanish on research impressions, concerns, and preferences regarding study attributes among people with MS. Invitations to take the survey were distributed by network members and partner organizations., Results: We included 2599 participants with MS (2111 White, 215 African American; 188 Hispanic). Consistently disliked study attributes included potential harms to health and confusing study information. Compared with White and non-Hispanic participants, respectively, African American (odds ratio [OR] = 2.05, P ≤ .001) and Hispanic (OR = 1.79, P = .003) participants were more concerned about being used by the research team. Hispanic participants were more concerned about research participation carrying risks to their legal status (OR = 1.70, P = .001). Hispanic (OR = 3.18, P ≤ .001) and African American (OR = 5.51 , P ≤ .001) participants were more likely to prefer for the study to benefit their own racial/ethnic group. A top concern across all groups was not being fully informed about the research., Conclusions: We found strong support for research across racial and ethnic groups; however, minority groups have specific concerns regarding mistrust, receiving poor-quality care, unemployment, health insurance, and legal status. Investigators wanting to recruit a diverse study population are advised to show how they have addressed these concerns and to communicate how the research will advance the science and literature and result in better care and/or other benefits to underrepresented communities., Competing Interests: Financial Disclosures: Dr Machemer receives financial compensation from Genentech Inc. Dr Livingston receives financial compensation from EMD Serono Inc. The other authors declare no conflicts of interest., (© 2021 Consortium of Multiple Sclerosis Centers.)
- Published
- 2021
- Full Text
- View/download PDF
48. Diagnostic accuracy of rapid antigen tests for COVID-19 compared to the viral genetic test in adults: a systematic review protocol.
- Author
-
DeArmond M, Feliciano S, Hirabayashi E, Duus KM, Else TA, and Stone AEL
- Subjects
- Adolescent, Adult, Female, Genetic Testing, Humans, Meta-Analysis as Topic, Pandemics, Pregnancy, SARS-CoV-2, Sensitivity and Specificity, Systematic Reviews as Topic, COVID-19
- Abstract
Objective: The objective of this diagnostic accuracy review is to evaluate the effectiveness of rapid antigen tests versus viral genetic PCR-based tests on COVID-19 diagnostic accuracy in adults 18 years and over., Introduction: Due to the rapidly changing nature of the COVID-19 pandemic, it is imperative that clinicians have access to the most relevant and effective tools and information required to combat this disease. Testing strategies are being developed continuously and need to be evaluated to ensure their appropriate implementation into clinical practice., Inclusion Criteria: This systematic review will include publications that are in the English language (originally or translated) and any gray literature pertaining to the tests of interest. All races, ages over 18, and geographic locations will be considered., Methods: MEDLINE (PubMed), Embase (Elsevier), Scopus (Elsevier), Qinsight (Quertle), and WHO COVID-19 database (World Health Organization) will be searched. Scopus, Qinsight, and WHO COVID-19 include gray literature. Studies in English published from November 2019 to the present will be considered. Animal studies and studies including pregnant women will be excluded. Retrieval of full-text studies, data extraction, and assessment of methodological quality will be performed independently by two reviewers. A custom data extraction table will be used. Findings will be graphically represented with two forest plots, one for sensitivity and the other for specificity. The strategy for meta-analysis includes producing a summary receiver operating characteristic curve and estimating the summary sensitivity/specificity for each threshold provided in the articles., Systematic Review Registration Number: PROSPERO CRD42020224250., Competing Interests: The authors declare no conflict of interest., (Copyright © 2021 JBI.)
- Published
- 2021
- Full Text
- View/download PDF
49. There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression.
- Author
-
Clery E, Pisapia P, Feliciano S, Vigliar E, Marano A, De Luca C, Malapelle U, Troncone G, and Bellevicine C
- Subjects
- Adenocarcinoma enzymology, Adenocarcinoma genetics, Adenocarcinoma pathology, Adenocarcinoma of Lung, Aged, Antineoplastic Agents adverse effects, Biomarkers, Tumor antagonists & inhibitors, Biomarkers, Tumor blood, Biomarkers, Tumor genetics, Biopsy, Carcinoma, Non-Small-Cell Lung enzymology, Carcinoma, Non-Small-Cell Lung genetics, Carcinoma, Non-Small-Cell Lung pathology, Carcinoma, Squamous Cell enzymology, Carcinoma, Squamous Cell genetics, Carcinoma, Squamous Cell pathology, Class I Phosphatidylinositol 3-Kinases genetics, DNA Mutational Analysis, Disease Progression, ErbB Receptors antagonists & inhibitors, ErbB Receptors blood, ErbB Receptors genetics, Female, Humans, Lung Neoplasms enzymology, Lung Neoplasms genetics, Lung Neoplasms pathology, Molecular Targeted Therapy, Predictive Value of Tests, Protein Kinase Inhibitors adverse effects, Time Factors, Tomography, X-Ray Computed, Treatment Outcome, Ultrasonography, Adenocarcinoma drug therapy, Antineoplastic Agents therapeutic use, Carcinoma, Non-Small-Cell Lung drug therapy, Carcinoma, Squamous Cell drug therapy, Drug Resistance, Neoplasm genetics, Lung Neoplasms drug therapy, Protein Kinase Inhibitors therapeutic use
- Abstract
Non-small cell lung carcinoma harbouring epidermal growth factor receptor ( EGFR ) mutation, usually progress after an initial response to tyrosine-kinase inhibitors (TKI). Liquid biopsy enables with a simple blood draw the accurate detection of EGFR p.T790M mutation, the most common resistance mechanism, avoiding the more invasive tissue re-biopsy. However, in a subset of cases, resistance mechanisms are more complex featuring both genetic and morphological changes. Here we report the case of a 67 years-old woman, affected by an EGFR mutated lung adenocarcinoma and treated by TKI. At disease progression, the patient developed a morphological transition to squamous cell carcinoma in association to the arising of a PIK3CA p.E542K mutant subclone. This case illustrates that, even in the "liquid biopsy" era, cytology can have still a role by providing an overall assessment of both morphology and genetic TKI resistance mechanisms., Competing Interests: Competing interests: None declared., (Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.)
- Published
- 2017
- Full Text
- View/download PDF
50. Regenerative Potential of Tissue-Engineered Nasal Chondrocytes in Goat Articular Cartilage Defects.
- Author
-
Mumme M, Steinitz A, Nuss KM, Klein K, Feliciano S, Kronen P, Jakob M, von Rechenberg B, Martin I, Barbero A, and Pelttari K
- Subjects
- Animals, Chondrocytes cytology, Chondrocytes transplantation, Female, Goats, Cartilage, Articular injuries, Cartilage, Articular physiology, Chondrocytes metabolism, Nasal Septum cytology, Nasal Septum metabolism, Regeneration, Tissue Engineering
- Abstract
Nasal chondrocytes (NC) were previously demonstrated to remain viable and to participate in the repair of articular cartilage defects in goats. Here, we investigated critical features of tissue-engineered grafts generated by NC in this large animal model, namely cell retention at the implantation site, architecture and integration with adjacent tissues, and effects on subchondral bone changes. In this study, isolated autologous goat NC (gNC) and goat articular chondrocytes (gAC, as control) were expanded, green fluorescent protein-labelled and seeded on a type I/III collagen membrane. After chondrogenic differentiation, tissue-engineered grafts were implanted into chondral defects (6 mm in diameter) in the stifle joint for 3 or 6 months. At the time of explantation, surrounding tissues showed no or very low (only in the infrapatellar fat pad <0.32%) migration of the grafted cells. In repair tissue, gNC formed typical structures of articular cartilage, such as flattened cells at the surface and column-like clusters in the middle layers. Semi-quantitative histological evaluation revealed efficient integration of the grafted tissues with the adjacent native cartilage and underlying subchondral bone. A significantly increased subchondral bone area, as a sign for the onset of osteoarthritis, was observed following treatment of cartilage defects with gAC-, but not with gNC-grafts. Our results reinforce the use of NC-based engineered tissue for articular cartilage repair and preliminarily indicate their potential for the treatment of early osteoarthritic defects.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.